Black Diamond Therapeutics

(NASDAQ) BDTX

Current Price$1.75

Market Cap$92.26M

Since IPO (2020)-96%

5 Year-87%

1 Year-29%

1 Month-29%

Black Diamond Therapeutics Financials at a Glance

Market Cap

$92.26M

Revenue (TTM)

$0.00

Net Income (TTM)

-$43.21M

EPS (TTM)

-$0.76

P/E Ratio

-2.12

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Price

$1.75

Volume

643,602

Open

$1.62

Price

$1.75

Volume

643,602

Open

$1.62

Previous Close

$1.61

Daily Range

$1.61 - $1.76

52-Week Range

$1.60 - $4.94

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Price

$1.75

Volume

643,602

Open

$1.62

Previous Close

$1.61

Daily Range

$1.61 - $1.76

52-Week Range

$1.60 - $4.94

Estimated Earnings Date

Aug 6, 2026

BDTX News

Black Diamond (BDTX) Q2 Loss Narrows 47%

Motley Fool Markets TeamAug 7, 2025

using a stethoscope listen to the heartbeat of patient (1)

Why Shares of Black Diamond Therapeutics Skyrocketed This Week

James HalleyJun 29, 2023

How Did Last Week's IPOs Perform?

David HaenFeb 6, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Black Diamond Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mark A. Velleca, MD, PhD

Website

www.blackdiamondtherapeutics.com

Headquarters

Cambridge, MA 02142, US

BDTX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-36.37%

Return on Capital

15.17%

Return on Assets

-32.51%

Earnings Yield

-47.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$92.26M

Shares Outstanding

57.30M

Volume

643.60K

Avg. Volume

1.40M

Financials (TTM)

Gross Profit

-$113.00K

Operating Income

-$53.27M

EBITDA

-$38.09M

Operating Cash Flow

-$34.03M

Capital Expenditure

$0.00

Free Cash Flow

-$34.03M

Cash & ST Invst.

$118.26M

Total Debt

$17.88M

Black Diamond Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$27.00K

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$92.26M

N/A

Market Cap/Employee

$3.84M

N/A

Employees

N/A

Net Income

-$9.04M

-116.0%

EBITDA

-$9.01M

-115.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$118.26M

-22.4%

Total Debt

$17.88M

-17.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$14.09M

-21.2%

Short Term Debt

$3.79M

+2.4%

Return on Assets

-32.51%

N/A

Return on Invested Capital

-44.99%

N/A

Free Cash Flow

-$10.23M

-119.2%

Operating Cash Flow

-$10.23M

-119.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AARDAardvark Therapeutics, Inc. Common Stock

AARDAardvark Therapeutics, Inc. Common Stock$4.53+7.09%

TNYATenaya Therapeutics, Inc.

TNYATenaya Therapeutics, Inc.$0.75+3.31%

CRBUCaribou Biosciences, Inc.

CRBUCaribou Biosciences, Inc.$1.67+0.58%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$4.58+0.77%

IVAInventiva S.A.

IVAInventiva S.A.$3.56-4.18%

AVTXAvalo Therapeutics, Inc.

AVTXAvalo Therapeutics, Inc.$18.11+1.55%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.18+0.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PLSMPulsenmore

PLSMPulsenmore$8.61+1.53%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.18-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.09-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.12+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.44-0.01%

RUNSunrun

RUNSunrun$16.06+0.25%

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$6.13+0.56%

Questions About BDTX

What is the current price of Black Diamond Therapeutics?

Black Diamond Therapeutics is trading at $1.74 per share.

What is the 52-week range for Black Diamond Therapeutics?

Over the past 52 weeks, Black Diamond Therapeutics has traded between $1.60 and $4.94.

How much debt does Black Diamond Therapeutics have?

As of the most recent reporting period, Black Diamond Therapeutics reported total debt of $17.88M.

How much cash does Black Diamond Therapeutics have on hand?

Black Diamond Therapeutics reported $30.07M in cash and cash equivalents in its most recent financial results.

What is Black Diamond Therapeutics’s dividend yield?

Black Diamond Therapeutics does not currently have a dividend yield.

Black Diamond Therapeutics

Black Diamond Therapeutics Financials at a Glance

BDTX News

Black Diamond (BDTX) Q2 Loss Narrows 47%

Why Shares of Black Diamond Therapeutics Skyrocketed This Week

How Did Last Week's IPOs Perform?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Black Diamond Therapeutics

BDTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Black Diamond Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BDTX

What is the current price of Black Diamond Therapeutics?

What is the 52-week range for Black Diamond Therapeutics?

How much debt does Black Diamond Therapeutics have?

How much cash does Black Diamond Therapeutics have on hand?

What is Black Diamond Therapeutics’s dividend yield?

Premium Investing Services